-transparent.png){kind=logo}
Bee venom--specific IgE and IgG antibodies were measured in the serum of beekeeepers, bee-allergic persons, and normal persons infrequently stung without adverse effects. Beekeepers, who are stung frequently and relatively "immune" to bee stings, are characterized by high serum levels of IgG- and low serum levels of IgE-specific antibodies. Bee-allergic individuals have high titers of bee venom--specific IgG. Following a bee sting, allergic individuals develop a rising titer of IgE antibodies, accompanied occasionally by a rise in IgG antibodies. Therapy with whole bee body extracts fail to effect IgE or IgG antibody titers. During the course of venom immunotherapy IgG-specific antibodies are stimulated and IgE-specific antibodies continue to decline. These observations suggest that: (1) bee sting allergy is a function of bee venom--specific IgE; (2) bee sting immunity is a function of bee venom--specific IgG; and (3) bee venom is an appropriate therapeutic antigen.
W C Light, and
R E Reisman, and
M Shimizu, and
C E Arbesman
September 1983,
Radioisotopes,
W C Light, and
R E Reisman, and
M Shimizu, and
C E Arbesman
July 1983,
Clinical allergy,
W C Light, and
R E Reisman, and
M Shimizu, and
C E Arbesman
August 1989,
Allergy,
W C Light, and
R E Reisman, and
M Shimizu, and
C E Arbesman
November 1980,
Klinische Wochenschrift,
W C Light, and
R E Reisman, and
M Shimizu, and
C E Arbesman
January 1993,
Pneumonologia i alergologia polska,
W C Light, and
R E Reisman, and
M Shimizu, and
C E Arbesman
January 1989,
International archives of allergy and applied immunology,
W C Light, and
R E Reisman, and
M Shimizu, and
C E Arbesman
January 2011,
PloS one,
W C Light, and
R E Reisman, and
M Shimizu, and
C E Arbesman
January 1984,
Eksperimentalna meditsina i morfologiia,
W C Light, and
R E Reisman, and
M Shimizu, and
C E Arbesman
July 1981,
Annals of allergy,
W C Light, and
R E Reisman, and
M Shimizu, and
C E Arbesman
April 1987,
Allergy,
